Fujifilm Eyes Avigan Use in Mild and Severe COVID-19 Cases: Exec

Fujifilm Toyama Chemical Executive Officer Koichi Yamada Fujifilm is looking to use its antiviral Avigan (favipiravir) not only for moderate cases of COVID-19 covered by its clinical trial but eventually also for mildly and severely ill patients with the disease,...read more